Leveraging the Emergency Department to Engage African American Women in HIV Pre-Exposure Prophylaxis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Number of participants with an increased willingness for pre-exposure prophylaxis (PrEP) uptake
研究概览
简要总结
African American (AA) women are more vulnerable to HIV infection than other women. Truvada, when used as pre-exposure prophylaxis (PrEP), is one of the most effective approaches for HIV prevention; however, PrEP use among AA women remains low and has not responded to traditional interventions. This study proposes for the first time an innovative computer-based motivational intervention, increasing PrEP uptake (iPrEP), which couples motivational messages woven into a traditional survey to raise awareness of risky sex and substance use behaviors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Participant)
盲法说明
Patients will be assigned to either an intervention or usual care
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Current HIV negative status (based on ED' HIV test outcome)
- •Condomless sex in the last 3 months
- •Substance use in the last 3 months
- •HIV testing during ED visit (usual care)
- •Has a non-emergent health condition
- •Has a working mobile device with them
排除标准
- •Ineligible for PrEP (see eligibility criteria to the right)
- •Assigned male at birth
- •An HIV positive status
- •Currently taking medication that are known contraindications for PrEP (brand name: Truvada)
- •Currently on PrEP
结局指标
主要结局
Number of participants with an increased willingness for pre-exposure prophylaxis (PrEP) uptake
时间窗: 6 months
Participants will be assessed for social norms and risk.
次要结局
- iPrEP feasibility and acceptability as assessed by the number of participants who believe that they had more information to make a better decision about being in a PrEP program after completing the survey intervention(baseline)
- iPrEP feasibility and acceptability as assessed by how much participant liked or disliked completing the survey(baseline)
- Number of participants with decrease in substance use(6 months)
- Number of participants with HIV seroconversion(6 months)
- Number of participants with a new sexually transmitted disease diagnosis(6 months)
- iPrEP feasibility and acceptability as assessed by how often participants relied on the survey questions being read aloud to be able to answer them(baseline)
- iPrEP feasibility and acceptability as assessed by the kind of help that participants needed from site staff in order to complete the survey(baseline)
- Number of participants with decreased high risk sex(6 months)
- iPrEP feasibility and acceptability as assessed by how participants felt about the length of the survey(baseline)
- iPrEP feasibility and acceptability as assessed by number of participants who needed help from site staff in order to complete the survey(baseline)
研究者
Mandy Hill
Associate Professor
The University of Texas Health Science Center, Houston